2-[4-[(4-amino-5-nitropyrimidin-2-yl)amino]-2-fluorophenoxy]benzonitrile
C17H11FN6O3 — CID 133332520
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[(4-amino-5-nitropyrimidin-2-yl)amino]-2-fluorophenoxy]benzonitrile
2-[4-[(4-amino-5-nitropyrimidin-2-yl)amino]-2-fluorophenoxy]benzonitrile (PubChem CID 133332520) has the molecular formula C17H11FN6O3 and a molecular weight of 366.31 g/mol. Its IUPAC name is 2-[4-[(4-amino-5-nitropyrimidin-2-yl)amino]-2-fluorophenoxy]benzonitrile.
Molecular Properties
| Compound Name | 2-[4-[(4-amino-5-nitropyrimidin-2-yl)amino]-2-fluorophenoxy]benzonitrile |
|---|---|
| PubChem CID | 133332520 |
| Molecular Formula | C17H11FN6O3 |
| Molecular Weight | 366.31 g/mol |
| Exact Mass | 366.09 |
| IUPAC Name | 2-[4-[(4-amino-5-nitropyrimidin-2-yl)amino]-2-fluorophenoxy]benzonitrile |
| SMILES | N#Cc1ccccc1Oc1ccc(Nc2ncc([N+](=O)[O-])c(N)n2)cc1F |
| InChI | InChI=1S/C17H11FN6O3/c18-12-7-11(22-17-21-9-13(24(25)26)16(20)23-17)5-6-15(12)27-14-4-2-1-3-10(14)8-19/h1-7,9H,(H3,20,21,22,23) |
| InChIKey | UKAKNMQWIYJKJH-UHFFFAOYSA-N |
| XLogP | 3.51 |
| TPSA | 139.99 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 366.31 |
| LogP ≤ 5 | 3.51 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 133332520 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.